ArticleOncotarget2019

Correction: HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody

Laurence Booth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.